News by Tag: Pacific Biosciences
Technological Advancements Driving Personalized Medicine Market
January 2, 2013
The US personalized medicine market is projected to grow at a CAGR of 9.5% during 2009-2015, says RNCOS in its research report.
January 2, 2013
The US personalized medicine market is projected to grow at a CAGR of 9.5% during 2009-2015, says RNCOS in its research report.
Personalized Medicine Rising As New Healthcare Paradigm
January 12, 2012
New drug developments and lower costs are among the factors boosting demand for personalized medicine, which is appearing as a novel model, says RNCOS in latest research report.
January 12, 2012
New drug developments and lower costs are among the factors boosting demand for personalized medicine, which is appearing as a novel model, says RNCOS in latest research report.
Personalized Medicine Market Exhibiting Exhilarant Prospective
December 26, 2011
Backed by factors, such as early detection of diseases and optimization of therapies, the US market for personalized medicine is likely to register a CAGR of 12% during 2009-2015, says a report by RNCOS.
December 26, 2011
Backed by factors, such as early detection of diseases and optimization of therapies, the US market for personalized medicine is likely to register a CAGR of 12% during 2009-2015, says a report by RNCOS.
Rising Private Participation to Drive Global Personalized Market
May 13, 2011
Personalized medicine market is expected to experience enormous growth in future on the back of heavy investments and interest shown by private players, says a new research report from RNCOS.
May 13, 2011
Personalized medicine market is expected to experience enormous growth in future on the back of heavy investments and interest shown by private players, says a new research report from RNCOS.
Personalized Medicines Set to Revolutionize Healthcare Sector
February 21, 2011
Treatment costs savings, patient compliance, drug safety & optimization of therapies will drive the growth of the global personalized medicines market, says RNCOS.
February 21, 2011
Treatment costs savings, patient compliance, drug safety & optimization of therapies will drive the growth of the global personalized medicines market, says RNCOS.